Literature DB >> 12846897

Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.

Shaji Kumar1, Thomas E Witzig, Philip R Greipp, S Vincent Rajkumar.   

Abstract

Bone marrow (BM) angiogenesis is increased in multiple myeloma (MM) and has prognostic significance. The presence of circulating plasma cells (PCs) in MM is associated with a poorer prognosis. We examined BM biopsies obtained at diagnosis of MM for angiogenesis, and correlated the microvessel density (MVD) with the presence of circulating PCs. There was a positive correlation between the absolute number of circulating PCs and the mean MVD. This relationship was independent of the disease activity and of the PC burden in the marrow. The increased angiogenesis may promote plasma cell proliferation and enable PC migration into the circulation.

Entities:  

Mesh:

Year:  2003        PMID: 12846897     DOI: 10.1046/j.1365-2141.2003.04428.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation.

Authors:  Wichard Vogel; Hans-Georg Kopp; Lothar Kanz; Hermann Einsele
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-23       Impact factor: 4.553

2.  Pretreatment 18F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myeloma.

Authors:  Yoshiaki Abe; Kentaro Narita; Hiroki Kobayashi; Akihiro Kitadate; Daisuke Miura; Masami Takeuchi; Eri O'uchi; Toshihiro O'uchi; Kosei Matsue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-28       Impact factor: 9.236

3.  Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

Authors:  W I Gonsalves; S V Rajkumar; V Gupta; W G Morice; M M Timm; P P Singh; A Dispenzieri; F K Buadi; M Q Lacy; P Kapoor; M A Gertz; S K Kumar
Journal:  Leukemia       Date:  2014-03-12       Impact factor: 11.528

Review 4.  Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.

Authors:  Michele Moschetta; Yawara Kawano; Antonio Sacco; Angelo Belotti; Rossella Ribolla; Marco Chiarini; Viviana Giustini; Diego Bertoli; Alessandra Sottini; Monica Valotti; Claudia Ghidini; Federico Serana; Michele Malagola; Luisa Imberti; Domenico Russo; Alessandro Montanelli; Giuseppe Rossi; Michaela R Reagan; Patricia Maiso; Bruno Paiva; Irene M Ghobrial; Aldo M Roccaro
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

5.  Prognostic value of circulating plasma cells in patients with multiple myeloma: A meta-analysis.

Authors:  Jia Li; Ningning Wang; Nahom Tesfaluul; Xiaojuan Gao; Shuai Liu; Baohong Yue
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

6.  Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.

Authors:  Valentina Marchica; Denise Toscani; Anna Corcione; Marina Bolzoni; Paola Storti; Rosanna Vescovini; Elisa Ferretti; Benedetta Dalla Palma; Emanuela Vicario; Fabrizio Accardi; Cristina Mancini; Eugenia Martella; Domenico Ribatti; Angelo Vacca; Vito Pistoia; Nicola Giuliani
Journal:  Cancers (Basel)       Date:  2019-03-06       Impact factor: 6.639

Review 7.  Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications.

Authors:  Charalampos Charalampous; Taxiarchis Kourelis
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

8.  Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.

Authors:  Davine Hofste Op Bruinink; Rowan Kuiper; Mark van Duin; Tom Cupedo; Vincent H J van der Velden; Remco Hoogenboezem; Bronno van der Holt; H Berna Beverloo; Erik T Valent; Michael Vermeulen; Francesca Gay; Annemiek Broijl; Hervé Avet-Loiseau; Nikhil C Munshi; Pellegrino Musto; Philippe Moreau; Sonja Zweegman; Niels W C J van de Donk; Pieter Sonneveld
Journal:  J Clin Oncol       Date:  2022-03-31       Impact factor: 50.717

9.  Bone vascularization in normal and disease conditions.

Authors:  Christian Carulli; Massimo Innocenti; Maria Luisa Brandi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-26       Impact factor: 5.555

Review 10.  Current applications of multiparameter flow cytometry in plasma cell disorders.

Authors:  T Jelinek; R Bezdekova; M Zatopkova; L Burgos; M Simicek; T Sevcikova; B Paiva; R Hajek
Journal:  Blood Cancer J       Date:  2017-10-20       Impact factor: 11.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.